Peptide TherapeuticsPeer Reviewed
Integrating Price Benchmarks and Comparative Clinical Effectiveness to Predict Initial Price Offers for Medicare Drug Price Negotiation (Initial Price Applicability Year 2027).
Authors (4)
Kevin H LiThe CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.
Emma M CousinThe CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.
Nico GabrielSkaggs School of Pharmacy, University of California San Diego, San Diego, CA, USA.
Sean D SullivanThe CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA; Department of Health Policy, London School of Economics and Political Science, London, England, UK. Electronic address: sdsull@uw.edu.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Unknown
Published
Oct 13, 2025
Abstract
Abstract not available - data parsing issue resolved
Keywords
CMSInflation Reduction ActMedicare Drug Price Negotiation Programdrug pricingmaximum fair price
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.